Literature DB >> 8748308

Comparison of rectal and perirectal swabs for detection of colonization with vancomycin-resistant enterococci.

J W Weinstein1, S Tallapragada, P Farrel, L M Dembry.   

Abstract

Patients whose gastrointestinal tracts are colonized with vancomycin-resistant enterococci (VRE) may serve as a reservoir for nosocomial transmission. We compared the sensitivities and concordance of several methods used to detect VRE colonization. Eighty-two paired rectal and perirectal swabs were obtained from 13 patients over a 9-day period. The sensitivity of both rectal and perirectal swabs was 79%. There was 100% concordance of culture results between simultaneously obtained rectal and perirectal swabs, and the quantities of growth were similar by these two methods of detection. Our data suggest that rectal and perirectal swabs are equally sensitive for the detection of VRE colonization.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8748308      PMCID: PMC228765          DOI: 10.1128/jcm.34.1.210-212.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit.

Authors:  L V Karanfil; M Murphy; A Josephson; R Gaynes; L Mandel; B C Hill; J M Swenson
Journal:  Infect Control Hosp Epidemiol       Date:  1992-04       Impact factor: 3.254

2.  Rapid detection of vancomycin-resistant enterococci.

Authors:  S C Edberg; C J Hardalo; C Kontnick; S Campbell
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

3.  Sensitivity of surveillance cultures for the detection of methicillin-resistant Staphylococcus aureus in a nursing-home-care unit.

Authors:  D L Sewell; S A Potter; C M Jacobson; L J Strausbaugh; T T Ward
Journal:  Diagn Microbiol Infect Dis       Date:  1993-07       Impact factor: 2.803

4.  High-level vancomycin-resistant enterococci causing hospital infections.

Authors:  A H Uttley; R C George; J Naidoo; N Woodford; A P Johnson; C H Collins; D Morrison; A J Gilfillan; L E Fitch; J Heptonstall
Journal:  Epidemiol Infect       Date:  1989-08       Impact factor: 2.451

5.  Major trends in the microbial etiology of nosocomial infection.

Authors:  D R Schaberg; D H Culver; R P Gaynes
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

6.  Vancomycin-resistant Enterococcus faecium in hospitalized children.

Authors:  L G Rubin; V Tucci; E Cercenado; G Eliopoulos; H D Isenberg
Journal:  Infect Control Hosp Epidemiol       Date:  1992-12       Impact factor: 3.254

7.  Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance.

Authors:  J M Boyce; S M Opal; J W Chow; M J Zervos; G Potter-Bynoe; C B Sherman; R L Romulo; S Fortna; A A Medeiros
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

8.  Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci.

Authors:  J F Boyle; S A Soumakis; A Rendo; J A Herrington; D G Gianarkis; B E Thurberg; B G Painter
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

  8 in total
  16 in total

Review 1.  Vancomycin-resistant enterococci.

Authors:  Y Cetinkaya; P Falk; C G Mayhall
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Vancomycin-resistant enterococci colonization in patients with hematological malignancies: screening and its cost-effectiveness.

Authors:  Habip Gedik; Funda Şimşek; Arzu Kantürk; Taner Yıldırmak; Deniz Arıca; Demet Aydın; Osman Yokuş; Naciye Demirel
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

3.  Test characteristics of perirectal and rectal swab compared to stool sample for detection of fluoroquinolone-resistant Escherichia coli in the gastrointestinal tract.

Authors:  Ebbing Lautenbach; Anthony D Harris; Eli N Perencevich; Irving Nachamkin; Pam Tolomeo; Joshua P Metlay
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

4.  Comparison of five chromogenic media for recovery of vancomycin-resistant enterococci from fecal samples.

Authors:  Nuntra Suwantarat; Ava Roberts; Jamie Prestridge; Renee Seeley; Sharon Speser; Christopher Harmon; Chi Zhang; Susan Henciak; Paul D Stamper; Tracy Ross; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2014-08-20       Impact factor: 5.948

5.  Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections.

Authors:  Mark J DiNubile; Joseph W Chow; Vilas Satishchandran; Adam Polis; Mary R Motyl; Murray A Abramson; Hedy Teppler
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

Review 6.  Screening for carbapenem-resistant Enterobacteriaceae: Who, When, and How?

Authors:  Sandra S Richter; Dror Marchaim
Journal:  Virulence       Date:  2016-11-04       Impact factor: 5.882

7.  Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii.

Authors:  Dror Marchaim; Shiri Navon-Venezia; David Schwartz; Jalal Tarabeia; Iris Fefer; Mitchell J Schwaber; Yehuda Carmeli
Journal:  J Clin Microbiol       Date:  2007-02-21       Impact factor: 5.948

8.  Sources of systematic errors in the epidemiology of vancomycin-resistant enterococci.

Authors:  N T Mutters; U Frank
Journal:  Infection       Date:  2013-02-06       Impact factor: 3.553

9.  Comparison of perirectal versus rectal swabs for detection of asymptomatic carriers of toxigenic Clostridium difficile.

Authors:  David S Rogers; Sirisha Kundrapu; Venkata C K Sunkesula; Curtis J Donskey
Journal:  J Clin Microbiol       Date:  2013-08-07       Impact factor: 5.948

10.  Nasal and perirectal colonization of vancomycin sensitive and resistant enterococci in patients of paediatrics ICU (PICU) of tertiary health care facilities.

Authors:  Muhammad Arfat Yameen; Saira Iram; Abdul Mannan; Shujaat Ali Khan; Naeem Akhtar
Journal:  BMC Infect Dis       Date:  2013-03-27       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.